dat.frank2008 | R Documentation |
Results from 4 case-control studies examining the association between the CASP8 -652 6N del promoter polymorphism and breast cancer risk.
dat.frank2008
The data frame contains the following columns:
study | character | study identifier |
bc.ins.ins | numeric | number of cases who have a homozygous insertion polymorphism |
bc.ins.del | numeric | number of cases who have a heterozygous insertion/deletion polymorphism |
bc.del.del | numeric | number of cases who have a homozygous deletion polymorphism |
ct.ins.ins | numeric | number of controls who have a homozygous insertion polymorphism |
ct.ins.del | numeric | number of controls who are heterozygous insertion/deletion polymorphism |
ct.del.del | numeric | number of controls who have a homozygous deletion polymorphism |
The 4 studies included in this dataset are case-control studies that have examined the association between the CASP8 -652 6N del promoter polymorphism and breast cancer risk. Breast cancer cases and controls were genotyped and either had a homozygous insertion, a heterozygous insertion/deletion, or a homozygous deletion polymorphism.
Ziegler et al. (2011) used the same dataset to illustrate the use of meta-analytic methods to examine deviations from Hardy-Weinberg equilibrium across multiple studies. The relative excess heterozygosity (REH) is the proposed measure for such a meta-analysis, which can be computed by setting measure="REH"
.
medicine, oncology, genetics, odds ratios
Wolfgang Viechtbauer, wvb@metafor-project.org, https://www.metafor-project.org
Frank, B., Rigas, S. H., Bermejo, J. L., Wiestler, M., Wagner, K., Hemminki, K., Reed, M. W., Sutter, C., Wappenschmidt, B., Balasubramanian, S. P., Meindl, A., Kiechle, M., Bugert, P., Schmutzler, R. K., Bartram, C. R., Justenhoven, C., Ko, Y.-D., Brüning, T., Brauch, H., Hamann, U., Pharoah, P. P. D., Dunning, A. M., Pooley, K. A., Easton, D. F., Cox, A. & Burwinkel, B. (2008). The CASP8 -652 6N del promoter polymorphism and breast cancer risk: A multicenter study. Breast Cancer Research and Treatment, 111(1), 139-144. https://doi.org/10.1007/s10549-007-9752-z
Ziegler, A., Steen, K. V. & Wellek, S. (2011). Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Research and Treatment, 128(1), 197–201. https://doi.org/10.1007/s10549-010-1295-z
### copy data into 'dat' and examine data dat <- dat.frank2008 dat ## Not run: ### load metafor package library(metafor) ### calculate log odds ratios comparing ins/del versus ins/ins dat <- escalc(measure="OR", ai=bc.ins.del, bi=bc.ins.ins, ci=ct.ins.del, di=ct.ins.ins, data=dat) ### fit random-effects model and get the pooled odds ratio (with 95% CI) res <- rma(yi, vi, data=dat) res predict(res, transf=exp, digits=2) ### calculate log odds ratios comparing del/del versus ins/ins dat <- escalc(measure="OR", ai=bc.del.del, bi=bc.ins.ins, ci=ct.del.del, di=ct.ins.ins, data=dat) ### fit random-effects model and get the pooled odds ratio (with 95% CI) res <- rma(yi, vi, data=dat) res predict(res, transf=exp, digits=2) ### calculate log odds ratios comparing ins/del+del/del versus ins/ins dat <- escalc(measure="OR", ai=bc.ins.del+bc.del.del, bi=bc.ins.ins, ci=ct.ins.del+ct.del.del, di=ct.ins.ins, data=dat) ### fit random-effects model and get the pooled odds ratio (with 95% CI) res <- rma(yi, vi, data=dat) res predict(res, transf=exp, digits=2) ############################################################################ ### compute the relative excess heterozygosity in the controls dat <- escalc(measure="REH", ai=ct.ins.ins, bi=ct.ins.del, ci=ct.del.del, slab=study, data=dat) ### fit random-effects model and get the pooled REH value (with 90% CI) res <- rma(yi, vi, data=dat, level=90) res predict(res, transf=exp, digits=2) ### draw forest plot forest(res, atransf=exp, header=TRUE, xlim=c(-1.5,1.5), at=log(c(0.5,5/7,1,7/5,2))) segments(log(5/7), -2, log(5/7), res$k+1, lty="dotted") segments(log(7/5), -2, log(7/5), res$k+1, lty="dotted") ## End(Not run)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.